XML 49 R27.htm IDEA: XBRL DOCUMENT v3.25.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of stock option activity under all of the Company's equity incentive plans

    

    

    

    

Weighted

    

Weighted

Average

Shares

Number of

Average

Remaining

Aggregate

Available for

Shares

Exercise

Contractual

Intrinsic

Grant

Outstanding

Price

Life (Years)

Value (000’s)

Available and outstanding as of December 31, 2024

92,020

296,391

$

50.50

7.97

$

26

2022 Equity incentive plan increase

220,106

Granted

 

(10,077)

 

10,077

 

3.72

 

 

Exercised

Forfeited

 

6,608

 

(6,608)

 

62.92

 

 

Available and outstanding as of March 31, 2025

308,657

299,860

$

48.62

7.85

$

Vested and exercisable as of March 31, 2025

 

100,004

$

88.70

 

5.29

$

 

Schedule of assumptions utilized for option grants

    

Three Months Ended

March 31, 

2025

    

2024

 

Risk-free interest rate

 

4.29

%  

4.49

%

Expected dividend yield

 

%  

%

Expected volatility

 

53.93

%  

54.89

%

Expected term (in years)

 

6.1

 

6.0

 

Schedule of stock-based compensation expense recognized in the Company's consolidated statements of operations

    

Three Months Ended

March 31, 

2025

    

2024

Cost of revenue, net

$

46

$

57

Research and development

 

148

 

122

Sales and marketing

 

21

 

48

General and administrative

 

207

 

107

Total

$

422

$

334